Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology
GlobeNewswire
SALT LAKE CITY, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision..